Current trends in chemical modifications of magnetic nanoparticles for targeted drug delivery in cancer chemotherapy

References

• Acharya S, Sahoo SK. 2011. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev. 63(3):170–183.
   PubMed Web of Science ®Google Scholar
• Alexiou C, Arnold W, Klein RJ, Parak FG, Hulin P, Bergemann C, Erhardt W, Wagenpfeil S, Luebbe AS. 2000. Locoregional cancer treatment with magnetic drug targeting. Cancer Res. 60(23):6641–6648.
   PubMed Web of Science ®Google Scholar
• Alexiou C, Jurgons R, Schmid RJ, Bergemann C, Henke J, Erhard W, Huenges E, Parak F. 2003. Magnetic drug targeting—biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Target. 11(3):139–149.
   PubMed Web of Science ®Google Scholar
• Alexiou C, Schmid RJ, Jurgons R, Kremer M, Wanner G, Bergemann C, Huenges E, Nawroth T, Arnold W, Parak FG. 2006. Targeting cancer cells: magnetic nanoparticles as drug carriers. Eur Biophys J. 35(5):446–450
   PubMed Web of Science ®Google Scholar
• Alirezaie Alavijeh A, Barati M, Barati M, Abbasi Dehkordi H. 2019. The potential of magnetic nanoparticles for diagnosis and treatment of cancer based on body magnetic field and organ-on-the-chip. Adv Pharm Bull. 9(3):360–373.
   PubMed Web of Science ®Google Scholar
• Andrä W. 1998. Magnetic hyperthermia. In: Andrä W, Novak H, editors. Magnetism in medicine. Berlin: Wiley-VCH; p. 455–470.
   Google Scholar
• Arias JL, López-Viota M, López-Viota J, Delgado ÁV. 2009. Development of iron/ethylcellulose (core/shell) nanoparticles loaded with diclofenac sodium for arthritis treatment. Int J Pharm. 382(1–2):270–276.
   PubMedGoogle Scholar
• Arruebo M, Fernández-Pacheco R, Ibarra MR, Santamaría J. 2007. Magnetic nanoparticles for drug delivery. Nano Today. 2(3):22–32.
   Web of Science ®Google Scholar
• Avval ZM, Malekpour L, Raeisi F, Babapoor A, Mousavi SM, Hashemi SA, Salari M. 2019. Introduction of magnetic and supermagnetic nanoparticles in new approach of targeting drug delivery and cancer therapy application. Drug Metab Rev. DOI:10.1080/03602532.2019.1697282
   PubMed Web of Science ®Google Scholar
• Bahrani S, Hashemi SA, Mousavi SM, Azhdari R. 2019. Zinc-based metal organic frameworks as nontoxic and biodegradable platforms for biomedical applications: review study. Drug Metab Rev. 51(3):1–39.
   PubMed Web of Science ®Google Scholar
• Baldi G, Ravagli C, Mazzantini F, Loudos G, Adan J, Masa M, Psimadas D, Fragogeorgi EA, Locatelli E, Innocenti C, et al. 2014. In vivo anticancer evaluation of the hyperthermic efficacy of anti-human epidermal growth factor receptor-targeted PEG-based nanocarrier containing magnetic nanoparticles. Int J Nanomedicine. 9:3037–3056.
   PubMed Web of Science ®Google Scholar
• Banerjee SS, Chen D-H. 2008. Cyclodextrin conjugated magnetic colloidal nanoparticles as a nanocarrier for targeted anticancer drug delivery. Nanotechnology. 19(26):265602.
   PubMed Web of Science ®Google Scholar
• Basel M, Balivada S, Wang H, Shrestha TB, Seo GM, Pyle M, Ayabaweera G, Dani R, Koper OB, Tamura M, et al. 2012. Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model. Int J Nanomedicine. 7:297.
   PubMed Web of Science ®Google Scholar
• Carrey J, Mehdaoui B, Respaud M. 2011. Simple models for dynamic hysteresis loop calculations of magnetic single-domain nanoparticles: application to magnetic hyperthermia optimization. J Appl Phys. 109(8):83921.
   Web of Science ®Google Scholar
• Chen Z, Wu C, Zhang Z, Wu W, Wang X, Yu Z. 2018. Synthesis, functionalization, and nanomedical applications of functional magnetic nanoparticles. Chin Chem Lett. 29(11):1601–1608.
   Web of Science ®Google Scholar
• Chicheł A, Skowronek J, Kubaszewska M, Kanikowski M. 2007. Hyperthermia – description of a method and a review of clinical applications. Rep Pract Oncol Radiother. 12(5):267–275.
   Google Scholar
• Cho H-Y, Lee T, Yoon J, Han Z, Rabie H, Lee K-B, Su WW, Choi J-W. 2018. Magnetic oleosome as a functional lipophilic drug carrier for cancer therapy. ACS Appl Mater Interfaces. 10(11):9301–9309.
   PubMed Web of Science ®Google Scholar
• Cho M, Cervadoro A, Ramirez M, Stigliano C, Brazdeikis A, Colvin V, Civera P, Key J, Decuzzi P. 2017. Assembly of iron oxide nanocubes for enhanced cancer hyperthermia and magnetic resonance imaging. Nanomaterials. 7(4):72.
   Web of Science ®Google Scholar
• Chomoucka J, Drbohlavova J, Huska D, Adam V, Kizek R, Hubalek J. 2010. Magnetic nanoparticles and targeted drug delivering. Pharmacol Res. 62(2):144–149.
   PubMed Web of Science ®Google Scholar
• Ciofani G, Riggio C, Raffa V, Menciassi A, Cuschieri A. 2009. A bi-modal approach against cancer: magnetic alginate nanoparticles for combined chemotherapy and hyperthermia. Med Hypotheses. 73(1):80–82.
   PubMed Web of Science ®Google Scholar
• Corchero JL, Villaverde A. 2009. Biomedical applications of distally controlled magnetic nanoparticles. Trends Biotechnol. 27(8):468–476.
   PubMed Web of Science ®Google Scholar
• Das P, Colombo M, Prosperi D. 2019. Recent advances in magnetic fluid hyperthermia for cancer therapy. Colloids Surf B. 174:42–55.
   PubMed Web of Science ®Google Scholar
• Deng L, Ren J, Li J, Leng J, Qu Y, Lin C, Shi D. 2015. Magnetothermally responsive star-block copolymeric micelles for controlled drug delivery and enhanced thermo-chemotherapy. Nanoscale. 7(21):9655–9663.
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Tso C, Oliver R, Gustafson CS, Secomb TW, Gross JF. 1989. Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. Int J Radiat Oncol Biol Phys. 17(1):91–99.
   PubMed Web of Science ®Google Scholar
• Dilnawaz F, Singh A, Mohanty C, Sahoo SK. 2010. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials. 31(13):3694–3706.
   PubMed Web of Science ®Google Scholar
• Drbohlavova J, Hrdy R, Adam V, Kizek R, Schneeweiss O, Hubalek J. 2009. Preparation and properties of various magnetic nanoparticles. Sensors. 9(4):2352–2362.
   PubMed Web of Science ®Google Scholar
• Du Y, Liu X, Liang Q, Liang X-J, Tian J. 2019. Optimization and design of magnetic ferrite nanoparticles with uniform tumor distribution for highly sensitive MRI/MPI performance and improved magnetic hyperthermia therapy. Nano Lett. 19(6):3618–3626.
   PubMed Web of Science ®Google Scholar
• Ebrahimi N, Rasoul-Amini S, Ebrahiminezhad A, Ghasemi Y, Gholami A, Seradj H. 2016. Comparative study on characteristics and cytotoxicity of bifunctional magnetic-silver nanostructures: synthesized using three different reducing agents. Acta Metall Sin (Engl Lett). 29(4):326–334.
   Web of Science ®Google Scholar
• Fang K, Song L, Gu Z, Yang F, Zhang Y, Gu N. 2015. Magnetic field activated drug release system based on magnetic PLGA microspheres for chemo-thermal therapy. Colloids Surf B. 136:712–720.
   PubMed Web of Science ®Google Scholar
• Farazi Z, Oromiehie A, Mousavi SM, Hashemi SA. 2018. Preparation of LDPE/EVA/PE-MA, nano clay blend composite in the stage potassium sorbate (KS) and garlic oil (GO) as an antimicrobial substance. Polym Sci. 4:1–12.
   Google Scholar
• Gaihre B, Khil MS, Lee DR, Kim HY. 2009. Gelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release study. Int J Pharm. 365(1–2):180–189.
   PubMed Web of Science ®Google Scholar
• Gaur U, Sahoo SK, De TK, Ghosh PC, Maitra A, Ghosh P. 2000. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int J Pharm. 202(1–2):1–10.
   PubMed Web of Science ®Google Scholar
• Gerweck LE, Nygaard TG, Burlett M. 1979. Response of cells to hyperthermia under acute and chronic hypoxic conditions. Cancer Res. 39(3):966–972.
   PubMed Web of Science ®Google Scholar
• Gholami A, Ebrahiminezhad A, Abootalebi N, Ghasemi Y. 2018. Synergistic evaluation of functionalized magnetic nanoparticles and antibiotics against Staphylococcus aureus and Escherichia coli. Pharm Nanotechnol. 6(4):276–286.
   PubMedGoogle Scholar
• Gholami A, Rasoul-Amini S, Ebrahiminezhad A, Abootalebi N-K, Niroumand U, Ebrahimi N, Ghasemi Y. 2016. Magnetic properties and antimicrobial effect of amino and lipoamino acid coated iron oxide nanoparticles. Minerva Biotechnol. 28(4):177–186.
   Web of Science ®Google Scholar
• Gholami A, Rasoul-Amini S, Ebrahiminezhad A, Seradj SH, Ghasemi Y. 2015. Lipoamino acid coated superparamagnetic iron oxide nanoparticles concentration and time dependently enhanced growth of human hepatocarcinoma cell line (Hep-G2). J Nanomater. 16(1):451405–451414.
   Google Scholar
• Guisasola E, Asín L, Beola L, de la Fuente JM, Baeza A, Vallet-Regí M. 2018. Beyond traditional hyperthermia: in vivo cancer treatment with magnetic-responsive mesoporous silica nanocarriers. ACS Appl Mater Interfaces. 10(15):12518–12525.
   PubMed Web of Science ®Google Scholar
• Häfeli UO, Riffle JS, Harris-Shekhawat L, Carmichael-Baranauskas A, Mark F, Dailey JP, Bardenstein D. 2009. Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol Pharm. 6(5):1417–1428.
   PubMedGoogle Scholar
• Hashemi SA, Mousavi SM, Ramakrishna S. 2019. Effective removal of mercury, arsenic and lead from aqueous media using polyaniline–Fe3O4–silver diethyldithiocarbamate nanostructures. J Clean Prod. 239:118023.
   Web of Science ®Google Scholar
• Hayashi K, Nakamura M, Miki H, Ozaki S, Abe M, Matsumoto T, Sakamoto W, Yogo T, Ishimura K. 2014. Magnetically responsive smart nanoparticles for cancer treatment with a combination of magnetic hyperthermia and remote-control drug release. Theranostics. 4(8):834–844.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Nakamura M, Sakamoto W, Yogo T, Miki H, Ozaki S, Abe M, Matsumoto T, Ishimura K. 2013. Superparamagnetic nanoparticle clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment. Theranostics. 3(6):366–376.
   PubMed Web of Science ®Google Scholar
• Hedayatnasab Z, Abnisa F, Daud W. 2017. Review on magnetic nanoparticles for magnetic nanofluid hyperthermia application. Mater Des. 123:174–196.
   Web of Science ®Google Scholar
• Hemery G, Genevois C, Couillaud F, Lacomme S, Gontier E, Ibarboure E, Lecommandoux S, Garanger E, Sandre O. 2017. Monocore vs. multicore magnetic iron oxide nanoparticles: uptake by glioblastoma cells and efficiency for magnetic hyperthermia. Mol Syst Des Eng. 2(5):629–639.
   Web of Science ®Google Scholar
• Hervault A, Thanh N. 2014. Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer. Nanoscale. 6(20):11553–11573.
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H. 2002. The cellular and molecular basis of hyperthermia. Crit Rev Oncol/Hematol. 43(1):33–56.
   PubMed Web of Science ®Google Scholar
• Hu F, Neoh K, Kang E. 2006. Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles. Biomaterials. 27(33):5725–5733.
   PubMed Web of Science ®Google Scholar
• Huang HS, Hainfeld JF. 2013. Intravenous magnetic nanoparticle cancer hyperthermia. Int J Nanomedicine. 8:2521–2532.
   PubMed Web of Science ®Google Scholar
• Huang W-C, Hu S-H, Liu K-H, Chen S-Y, Liu D-M. 2009. A flexible drug delivery chip for the magnetically-controlled release of anti-epileptic drugs. J Control Release. 139(3):221–228.
   PubMed Web of Science ®Google Scholar
• Issels RD. 2008. Hyperthermia adds to chemotherapy. Eur J Cancer. 44(17):2546–2554.
   PubMed Web of Science ®Google Scholar
• Ito A, Tanaka K, Honda H, Abe S, Yamaguchi H, Kobayashi T. 2003. Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using magnetite nanoparticles. J Biosci Bioeng. 96(4):364–369.
   PubMed Web of Science ®Google Scholar
• Jain TK, Richey J, Strand M, Leslie-Pelecky DL, Flask CA, Labhasetwar V. 2008. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials. 29(29):4012–4021.
   PubMed Web of Science ®Google Scholar
• Jang J-t, Lee J, Seon J, Ju E, Kim M, Kim YI, Kim MG, Takemura Y, Arbab AS, Kang KW, et al. 2018. Giant magnetic heat induction of magnesium-doped γ-Fe2O3 superparamagnetic nanoparticles for completely killing tumors. Adv Mater. 30(6):1704362.
   Web of Science ®Google Scholar
• Jose J, Kumar R, Harilal S, Mathew GE, Prabhu A, Uddin MS, Aleya L, Kim H, Mathew B. 2019. Magnetic nanoparticles for hyperthermia in cancer treatment: an emerging tool. Environ Sci Pollut Res. DOI:10.1007/s11356-019-07231-2
   Web of Science ®Google Scholar
• Jurek PM, Zabłocki K, Waśko U, Mazurek MP, Otlewski J, Jeleń F. 2017. Anti-FGFR1 aptamer-tagged superparamagnetic conjugates for anticancer hyperthermia therapy. Int J Nanomedicine. 12:2941–2950.
   PubMed Web of Science ®Google Scholar
• Jurgons R, Seliger C, Hilpert A, Trahms L, Odenbach S, Alexiou C. 2006. Drug loaded magnetic nanoparticles for cancer therapy. J Phys Condens Matter. 18(38):S2893.
   Web of Science ®Google Scholar
• Kerr JF, Winterford CM, Harmon BV. 1994. Apoptosis. Its significance in cancer and cancer therapy. Cancer. 73(8):2013–2026.
   PubMed Web of Science ®Google Scholar
• Kim H-C, Kim E, Jeong SW, Ha T-L, Park S-I, Lee SG, Lee SJ, Lee SW. 2015. Magnetic nanoparticle-conjugated polymeric micelles for combined hyperthermia and chemotherapy. Nanoscale. 7(39):16470–16480.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Ebara M, Aoyagi T. 2013. A smart hyperthermia nanofiber with switchable drug release for inducing cancer apoptosis. Adv Funct Mater. 23(46):5753–5761.
   Web of Science ®Google Scholar
• Kobayashi H, Watanabe R, Choyke PL. 2014. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? Theranostics. 4(1):81–89.
   Web of Science ®Google Scholar
• Kolhatkar AG, Jamison AC, Litvinov D, Willson RC, Lee TR. 2013. Tuning the magnetic properties of nanoparticles. Int J Mol Sci. 14(8):15977–16009.
   PubMed Web of Science ®Google Scholar
• Kumar S, Daverey A, Khalilzad-Sharghi V, Sahu NK, Kidambi S, Othman SF, Bahadur D. 2015. Theranostic fluorescent silica encapsulated magnetic nanoassemblies for in vitro MRI imaging and hyperthermia. RSC Adv. 5(66):53180–53188.
   Web of Science ®Google Scholar
• Lemine O. 2019. Magnetic hyperthermia therapy using hybrid magnetic nanostructures. In: Hybrid nanostructures for cancer theranostics. Amsterdam: Elsevier; p. 125–138.
   Google Scholar
• Lepock JR. 2003. Cellular effects of hyperthermia: relevance to the minimum dose for thermal damage. Int J Hyperthermia. 19(3):252–266.
   PubMed Web of Science ®Google Scholar
• Liao S-H, Liu C-H, Bastakoti BP, Suzuki N, Chang Y, Yamauchi Y, Lin F-H, Wu KC. 2015. Functionalized magnetic iron oxide/alginate core-shell nanoparticles for targeting hyperthermia. Int J Nanomedicine. 10:3315–3327.
   PubMed Web of Science ®Google Scholar
• Lin M, Zhang D, Huang J, Zhang J, Xiao W, Yu H, Zhang L, Ye J. 2013. The anti-hepatoma effect of nanosized Mn–Zn ferrite magnetic fluid hyperthermia associated with radiation in vitro and in vivo. Nanotechnology. 24(25):255101.
   PubMed Web of Science ®Google Scholar
• Ling Y, Tang X, Wang F, Zhou X, Wang R, Deng L, Shang T, Liang B, Li P, Ran H, et al. 2017. Highly efficient magnetic hyperthermia ablation of tumors using injectable polymethylmethacrylate–Fe3O4. RSC Adv. 7(5):2913–2918.
   Web of Science ®Google Scholar
• Liu XL, Ng CT, Chandrasekharan P, Yang HT, Zhao LY, Peng E, Lv YB, Xiao W, Fang J, Yi JB, et al. 2016. Synthesis of ferromagnetic Fe0.6Mn0.4O nanoflowers as a new class of magnetic theranostic platform for in vivo T1-T2 dual-mode magnetic resonance imaging and magnetic hyperthermia therapy. Adv Healthcare Mater. 5(16):2092–2104.
   Web of Science ®Google Scholar
• Liu XL, Yang Y, Ng CT, Zhao LY, Zhang Y, Bay BH, Fan HM, Ding J. 2015. Magnetic vortex nanorings: a new class of hyperthermia agent for highly efficient in vivo regression of tumors. Adv Mater. 27(11):1939–1944.
   PubMed Web of Science ®Google Scholar
• Maeda H, Nakamura H, Fang J. 2013. The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Deliv Rev. 65(1):71–79.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Simchi A, Imani M, Shokrgozar MA, Milani AS, Häfeli UO, Stroeve P. 2010. A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. Colloids Surf B. 75(1):300–309.
   PubMed Web of Science ®Google Scholar
• Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, Feussner A, von Deimling A, Waldoefner N, Felix R, et al. 2007. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol. 81(1):53–60.
   PubMed Web of Science ®Google Scholar
• Majeed J, Pradhan L, Ningthoujam RS, Vatsa RK, Bahadur D, Tyagi AK. 2014. Enhanced specific absorption rate in silanol functionalized Fe3O4 core–shell nanoparticles: study of Fe leaching in Fe3O4 and hyperthermia in L929 and HeLa cells. Colloids Surf B. 122:396–403.
   PubMed Web of Science ®Google Scholar
• Makridis A, Topouridou K, Tziomaki M, Sakellari D, Simeonidis K, Angelakeris M, Yavropoulou MP, Yovos JG, Kalogirou O. 2014. In vitro application of Mn-ferrite nanoparticles as novel magnetic hyperthermia agents. J Mater Chem B. 2(47):8390–8398.
   Web of Science ®Google Scholar
• Matsumura Y, Maeda H. 1986. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46(12 Pt 1):6387–6392.
   PubMed Web of Science ®Google Scholar
• McBain SC, Yiu HH, Dobson J. 2008. Magnetic nanoparticles for gene and drug delivery. Int J Nanomedicine. 3(2):169–180.
   PubMed Web of Science ®Google Scholar
• Mondal S, Manivasagan P, Bharathiraja S, Santha Moorthy M, Nguyen V, Kim H, Nam S, Lee K, Oh J. 2017. Hydroxyapatite coated iron oxide nanoparticles: a promising nanomaterial for magnetic hyperthermia cancer treatment. Nanomaterials. 7(12):426.
   Web of Science ®Google Scholar
• Monfared M, Taghizadeh S, Zare-Hoseinabadi A, Mousavi SM, Hashemi SA, Ranjbar S, Amani AM. 2019. Emerging frontiers in drug release control by core–shell nanofibers: a review. Drug Metab Rev. 51(4):589–611.
   PubMedGoogle Scholar
• Mornet S, Vasseur S, Grasset F, Duguet E. 2004. Magnetic nanoparticle design for medical diagnosis and therapy. J Mater Chem. 14(14):2161–2175.
   Web of Science ®Google Scholar
• Mousavi S, Hashemi S, Zarei M, Amani A, Babapoor A. 2018. Nanosensors for chemical and biological and medical applications. Med Chem. 8(8):205.
   Google Scholar
• Mousavi SM, Hashemi SA, Ramakrishna S, Esmaeili H, Bahrani S, Koosha M, Babapoor A. 2019. Green synthesis of supermagnetic Fe3O4–MgO nanoparticles via Nutmeg essential oil toward superior anti-bacterial and anti-fungal performance. J Drug Deliv Sci Technol. 54:101352.
   Web of Science ®Google Scholar
• Mousavi SM, Hashemi SA, Zarei M, Bahrani S, Savardashtaki A, Esmaeili H, Lai CW, Mazraedoost S, Abassi M, Ramavandi B. 2020. Data on cytotoxic and antibacterial activity of synthesized Fe3O4 nanoparticles using Malva sylvestris. Data Brief. 28:104929.
   PubMedGoogle Scholar
• Mousavi SM, Soroshnia S, Hashemi SA, Babapoor A, Ghasemi Y, Savardashtaki A, Amani AM. 2019. Graphene nano-ribbon based high potential and efficiency for DNA, cancer therapy and drug delivery applications. Drug Metab Rev. 51(1):91–104.
   PubMed Web of Science ®Google Scholar
• Nedelcu G. 2008. Magnetic nanoparticles impact on tumoral cells in the treatment by magnetic fluid hyperthermia. Dig J Nanomater Biostruct. 3(3):103–107.
   Web of Science ®Google Scholar
• Pala K, Serwotka A, Jeleń F, Jakimowicz P, Otlewski J. 2014. Tumor-specific hyperthermia with aptamer-tagged superparamagnetic nanoparticles. Int J Nanomedicine. 9:67–76.
   PubMed Web of Science ®Google Scholar
• Pankhurst QA, Connolly J, Jones S, Dobson J. 2003. Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys. 36(13):R167–R181.
   Web of Science ®Google Scholar
• Parhi P, Mohanty C, Sahoo SK. 2012. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy. Drug Discov Today. 17(17–18):1044–1052.
   PubMed Web of Science ®Google Scholar
• Parvin S, Matsui J, Sato E, Miyashita T. 2007. Side-chain effect on Langmuir and Langmuir–Blodgett film properties of poly(N-alkylmethacrylamide)-coated magnetic nanoparticle. J Colloid Interface Sci. 313(1):128–134.
   PubMed Web of Science ®Google Scholar
• Pouponneau P, Leroux J-C, Martel S. 2009. Magnetic nanoparticles encapsulated into biodegradable microparticles steered with an upgraded magnetic resonance imaging system for tumor chemoembolization. Biomaterials. 30(31):6327–6332.
   PubMed Web of Science ®Google Scholar
• Qu Y, Li J, Ren J, Leng J, Lin C, Shi D. 2014a. Enhanced magnetic fluid hyperthermia by micellar magnetic nanoclusters composed of MnxZn1–xFe2O4 nanoparticles for induced tumor cell apoptosis. ACS Appl Mater Interfaces. 6(19):16867–16879.
   PubMed Web of Science ®Google Scholar
• Qu Y, Li J, Ren J, Leng J, Lin C, Shi D. 2014b. Enhanced synergism of thermo-chemotherapy by combining highly efficient magnetic hyperthermia with magnetothermally-facilitated drug release. Nanoscale. 6(21):12408–12413.
   PubMed Web of Science ®Google Scholar
• Raee MJ, Ebrahiminezhad A, Gholami A, Ghoshoon MB, Ghasemi Y. 2018. Magnetic immobilization of recombinant E. coli producing extracellular asparaginase: an effective way to intensify downstream process. Sep Sci Technol. 53(9):1397–1404.
   Web of Science ®Google Scholar
• Rana S, Jadhav NV, Barick K, Pandey B, Hassan P. 2014. Polyaniline shell cross-linked Fe3O4 magnetic nanoparticles for heat activated killing of cancer cells. Dalton Trans. 43(32):12263–12271.
   PubMed Web of Science ®Google Scholar
• Reshmi G, Kumar PM, Malathi M. 2009. Preparation, characterization and dielectric studies on carbonyl iron/cellulose acetate hydrogen phthalate core/shell nanoparticles for drug delivery applications. Int J Pharm. 365(1–2):131–135.
   PubMedGoogle Scholar
• Roque AC, Bicho A, Batalha IL, Cardoso AS, Hussain A. 2009. Biocompatible and bioactive gum Arabic coated iron oxide magnetic nanoparticles. J Biotechnol. 144(4):313–320.
   PubMed Web of Science ®Google Scholar
• Sadhukha T, Wiedmann TS, Panyam J. 2013. Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy. Biomaterials. 34(21):5163–5171.
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Misra R, Parveen S. 2017. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine. 8:147–166.
   Google Scholar
• Shevtsov M, Multhoff G. 2016. Recent developments of magnetic nanoparticles for theranostics of brain tumor. Curr Drug Metab. 17(8):737–744.
   PubMed Web of Science ®Google Scholar
• Shinkai M. 2002. Functional magnetic particles for medical application. J Biosci Bioeng. 94(6):606–613.
   PubMed Web of Science ®Google Scholar
• Shubayev VI, Pisanic IIT, Jin S. 2009. Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev. 61(6):467–477.
   PubMed Web of Science ®Google Scholar
• Siddiqui M, Nizamuddin S, Baloch HA, Mubarak N, Al-Ali M, Mazari SA, Bhutto A, Abro R, Srinivasan M, Griffin G. 2019. Fabrication of advance magnetic carbon nano-materials and their potential applications: a review. J Environ Chem Eng. 7(1):102812.
   Web of Science ®Google Scholar
• Siemann DW. 2011. The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by tumor-vascular disrupting agents. Cancer Treatment Rev. 37(1):63–74.
   PubMed Web of Science ®Google Scholar
• Singh A, Dilnawaz F, Mewar S, Sharma U, Jagannathan N, Sahoo SK. 2011. Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy. ACS Appl Mater Interfaces. 3(3):842–856.
   PubMed Web of Science ®Google Scholar
• Song CW. 1984. Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Res. 44(10 Suppl.):4721s–4730s.
   PubMed Web of Science ®Google Scholar
• Song CW, Rhee JG, Levitt SH. 1980. Blood flow in normal tissues and tumors during hyperthermia. J Natl Cancer Inst. 64(1):119–124.
   PubMedGoogle Scholar
• Song M, Zhang Y, Hu S, Song L, Dong J, Chen Z, Gu N. 2012. Influence of morphology and surface exchange reaction on magnetic properties of monodisperse magnetite nanoparticles. Colloids Surf A. 408:114–121
   Google Scholar
• Storm FK, Harrison WH, Elliott RS, Morton DL. 1979. Normal tissue and solid tumor effects of hyperthermia in animal models and clinical trials. Cancer Res. 39(6 Pt 2):2245–2251.
   PubMed Web of Science ®Google Scholar
• Sun C, Lee JS, Zhang M. 2008. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev. 60(11):1252–1265.
   PubMed Web of Science ®Google Scholar
• Wang F, Yang Y, Ling Y, Liu J, Cai X, Zhou X, Tang X, Liang B, Chen Y, Chen H, et al. 2017. Injectable and thermally contractible hydroxypropyl methyl cellulose/Fe3O4 for magnetic hyperthermia ablation of tumors. Biomaterials. 128:84–93.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhou Y, Sun W. 2009. Preparation and characterization of antifouling thermosensitive magnetic nanoparticles for applications in biomedicine. Mater Sci Eng C. 29(4):1196–1200.
   Google Scholar
• Wang X, Wang L, He X, Zhang Y, Chen L. 2009. A molecularly imprinted polymer-coated nanocomposite of magnetic nanoparticles for estrone recognition. Talanta. 78(2):327–332.
   PubMed Web of Science ®Google Scholar
• Wiekhorst F, Jurgons R, Eberbeck D, Sander T, Steinhoff U, Hartwig S, Alexiou C, Trahms L. 2005. SQUID system with integrated superconducting shield for monitoring of drug targeting with magnetic nanoparticles in animals. Biomed Tech. 50(2):609–610.
   Google Scholar
• Wu H, Song L, Chen L, Huang Y, Wu Y, Zang F, An Y, Lyu H, Ma M, Chen J, et al. 2017. Injectable thermosensitive magnetic nanoemulsion hydrogel for multimodal-imaging-guided accurate thermoablative cancer therapy. Nanoscale. 9(42):16175–16182.
   PubMed Web of Science ®Google Scholar
• Wydra RJ, Rychahou PG, Evers BM, Anderson KW, Dziubla TD, Hilt JZ. 2015. The role of ROS generation from magnetic nanoparticles in an alternating magnetic field on cytotoxicity. Acta Biomater. 25:284–290.
   PubMed Web of Science ®Google Scholar
• Xie L, Jin W, Chen H, Zhang Q. 2019. Superparamagnetic iron oxide nanoparticles for cancer diagnosis and therapy. J Biomed Nanotechnol. 15(2):215–416.
   PubMed Web of Science ®Google Scholar
• Xie J, Zhang Y, Yan C, Song L, Wen S, Zang F, Chen G, Ding Q, Yan C, Gu N. 2014. High-performance PEGylated Mn–Zn ferrite nanocrystals as a passive-targeted agent for magnetically induced cancer theranostics. Biomaterials. 35(33):9126–9136.
   PubMed Web of Science ®Google Scholar
• Xing W, Zhuo S-P, Gao X-l. 2009. α-Fe-incorporated nanoporous carbon with magnetic properties. Mater Lett. 63(13–14):1177–1179.
   Web of Science ®Google Scholar
• Xu C, Zheng Y, Gao W, Xu J, Zuo G, Chen Y, Zhao M, Li J, Song J, Zhang N. 2015. Magnetic hyperthermia ablation of tumors using injectable Fe3O4/calcium phosphate cement. ACS Appl Mater Interfaces. 7(25):13866–13875.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhu Y, Kaskel S. 2015. A smart magnetic nanosystem with controllable drug release and hyperthermia for potential cancer therapy. RSC Adv. 5(121):99875–99883.
   Web of Science ®Google Scholar
• Zakeri A, Amin Jadidi Kouhbanani M, Beheshtkhoo N, Beigi V, Mousavi SM, Hashemi SA, Karimi Zade A, Amani A, Savardashtaki A, Mirzaei E. 2018. Polyethylenimine-based nanocarriers in co-delivery of drug and gene: a developing horizon. Nano Rev Exp. 9:1488497.
   PubMed Web of Science ®Google Scholar
• Zboril R, Mashlan M, Petridis D. 2002. Iron (III) oxides from thermal processes synthesis, structural and magnetic properties, Mössbauer spectroscopy characterization, and applications. Chem Mater. 14(3):969–982.
   Web of Science ®Google Scholar
• Zhai Y, Xie H, Gu H. 2009. Effects of hyperthermia with dextran magnetic fluid on the growth of grafted H22 tumor in mice. Int J Hyperthermia. 25(1):65–71.
   PubMed Web of Science ®Google Scholar
• Zhou L, Yuan J, Yuan W, Sui X, Wu S, Li Z, Shen D. 2009. Synthesis, characterization, and controllable drug release of pH-sensitive hybrid magnetic nanoparticles. J Magn Magn Mater. 321(18):2799–2804.
   Web of Science ®Google Scholar
• Zhou L, Yuan J, Yuan W, Zhou M, Wu S, Li Z, Xing X, Shen D. 2009. Synthesis and characterization of multi-functional hybrid magnetite nanoparticles with biodegradability, superparamagnetism, and fluorescence. Mater Lett. 63(18–19):1567–1570.
   Web of Science ®Google Scholar
• Zhu X, Zhang H, Huang H, Zhang Y, Hou L, Zhang Z. 2015. Functionalized graphene oxide-based thermosensitive hydrogel for magnetic hyperthermia therapy on tumors. Nanotechnology. 26(36):365103.
   PubMed Web of Science ®Google Scholar